Medline Inc. (MDLN) Current Ratio
- Current ratio · latest quarter: Value 4.33×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.33× | Current assets / current liabilities. $11.74B ÷ $2.71B ≈ 4.33× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 11.74B USD | Assets, Current |
| Current obligations | 2.71B USD | Liabilities, Current |
| Cash and equivalents | 2.33B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.66B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 4.67B USD | Inventory, Net |
| Payables | 1.04B USD | Accounts Payable, Current |
| Borrowing debt due within one year | 28.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $11.74B | $2.71B | $2.33B | (m) | $3.66B | $4.67B | $1.04B | $28.00M | 4.33× |
| 2026-03-28 | $11.18B | $2.54B | $2.24B | (m) | $3.67B | $4.81B | $932.00M | $76.00M | 4.41× |
| 2025-12-31 | $10.68B | $2.49B | $1.94B | (m) | $3.53B | $4.77B | $961.00M | $76.00M | 4.29× |
| 2024-12-31 | $8.27B | $2.44B | $199.00M | (m) | $3.22B | $4.46B | $869.00M | $76.00M | 3.39× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.